Galderma Laboratories, L.P. v. Brenner

Summary

The Texas Business Court grants Galderma Laboratories, L.P.’s application for a temporary injunction in part against former executive Erick Brenner. The court finds a probable right of recovery based on Brenner’s alleged violation of a noncompete covenant through his service as CEO of direct competitor Prollenium, but finds insufficient evidence at this stage to support relief based on confidentiality, nonsolicitation, or trade-secret claims. The court addresses the temporal, activity, and geographic scope of the noncompete and orders statutory reformation where necessary.

Holdings

1. Galderma established a probable right to recover for Brenner's violation of the noncompete covenant because the agreement was likely ancillary to an otherwise enforceable agreement, contained reasonable limitations as to time, geographic scope, and activity as applied after reformation, and covered Brenner's service as CEO of a direct competitor in the same product segment.
2. Galderma established a probable, imminent, and irreparable injury because Brenner's continued service as CEO of a direct competitor created an ongoing risk that his recent and detailed knowledge of Galderma's strategy would influence competitive decisions in ways that could not be adequately measured or remedied by damages.
3. The court reformed the noncompete under section 15.51(c) by removing language covering ownership, operation, or management of any competitor and by removing geographic coverage based solely on Brenner's receipt of confidential information about a territory without material involvement or operational responsibility.
4. Galderma did not establish a probable right to recovery on the customer-nonsolicitation, worker-nonsolicitation, confidentiality, or TUTSA claims at the temporary-injunction stage.

Questions Presented

1. Whether Galderma established a viable claim and probable right to relief under the protective covenants agreement.
2. Whether Galderma established a probable, imminent, and irreparable injury warranting a temporary injunction.
3. Whether the noncompete's time, geographic, and activity restrictions were reasonable under Texas law.
4. Whether the noncompete required reformation under Texas Business and Commerce Code section 15.51(c).
5. Whether Galderma established a probable right to temporary injunctive relief for customer solicitation, worker solicitation, confidentiality breaches, or trade-secret misappropriation.

Disposition

other